Phase I Study to Investigate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of CJ-12406 in Healthy Male Subjects

Summary

Study objectives * To evaluate the safety, tolerability, and pharmacokinetics of escalating single oral doses of CJ-12406 in healthy male subjects. * To evaluate the pharmacodynamics of CJ-12406 after multiple oral administrations to healthy male subjects. * To evaluate the effect of food on the pharmacokinetic of a single oral dose of CJ-12406 in healthy male subjects.

Timeline

Start

2011-05

Primary completion

2012-04

Completion

2012-06

Drugs

Indications